Delivery Order SPE2DB22D3102-SPE2DB25FL3CC
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,541.99 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is an antiretroviral combination therapy used for HIV treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $14,373.49 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count unit dose packaging) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $12.5K to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency Medical Supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,675.06 firm fixed-price delivery order for TRIUMEQ 600-50-300 mg tablets (30-unit pack) to be delivered to Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA Troop Support Medical. TRIUMEQ is an antiretroviral combination medication used in HIV...
- The Defense Logistics Agency awarded a $38,550.86 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-unit packaging) with an ultimate completion date of August 14, 2025. This firm fixed-price contract represents a non-set-aside competitive award, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. TRIUMEQ is a prescription antiretroviral medication used in HIV treatment, indicating this delivery supports federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) valued at $12,781.54 under a firm fixed price contract type. The award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a competitively awarded, non-set-aside procurement. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,910.52 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets (30-count units) on September 4, 2025, with completion expected by September 5, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $12,886.43 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a Delivery Order valued at $7,320.36 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025. TRIUMEQ is an HIV treatment medication combining dolutegravir, abacavir, and lamivudine, reflecting the military and veteran healthcare system's need for critical antiretroviral therapies....
- The Defense Logistics Agency awarded a $11,096.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with a completion date of August 4, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026. The delivery will be performed...